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KEY POINTS SUMMARY 35 
 36 
 Dietary nitrate supplementation increases plasma nitrite concentration, which provides an 37 
oxygen-independent source of nitric oxide and can delay skeletal muscle fatigue. 38 
 Nitrate supplementation has been shown to increase myofibre calcium release and force 39 
production in mouse skeletal muscle during contractions at a supra-physiological oxygen 40 
tension, but it is unclear whether nitrite exposure can delay fatigue development and 41 
improve myofibre calcium handling at a near-physiological oxygen tension.  42 
 Single mouse muscle fibres acutely treated with nitrite had a lower force and cytosolic 43 
calcium concentration during single non-fatiguing contractions at a near-physiological 44 
oxygen tension. 45 
 Nitrite treatment delayed fatigue development during repeated fatiguing isometric 46 
contractions at near-physiological, but not at supra-physiological, oxygen tension in 47 
combination with better maintenance of myofilament calcium sensitivity and 48 
sarcoplasmic reticulum calcium pumping. 49 
 These findings improve understanding of the mechanisms by which increased skeletal 50 
muscle nitrite exposure might be ergogenic and imply that this is related to improved 51 
calcium handling.  52 
 53 







) supplementation, which increases plasma nitrite (NO2
-
) concentration, has 57 
been reported to attenuate skeletal muscle fatigue development.  Sarcoplasmic reticulum (SR) 58 
calcium (Ca
2+





 incubation at a supra-physiological PO2 but it is unclear whether NO2
-
 60 
incubation can alter Ca
2+
 handling and fatigue development at a near-physiological PO2.  We 61 
hypothesised that NO2
-
 treatment would improve Ca
2+
 handling and delay fatigue at a 62 
physiological PO2 in intact single mouse skeletal muscle fibres. Each muscle fibre was perfused 63 
with Tyrode’s solution pre-equilibrated with either 20% (PO2~150 Torr) or 2% O2 (PO2 =15.6 64 
Torr) in the absence and presence of 100 µM NaNO2.  At supra-physiological PO2 (i.e., 20% O2), 65 
time to fatigue was lowered by 34% with NaNO2 (control: 257 ± 94 vs. NaNO2: 159 ± 46 s, 66 
d=1.63, P<0.05), but extended by 21% with NaNO2 at 2% O2 (control: 308 ± 217 vs. NaNO2: 67 
368 ± 242 s, d=1.14, P<0.01). During the fatiguing contraction protocol completed with NaNO2 68 




]c) was not different (P>0.05) but [Ca
2+
]c 69 
accumulation between contractions was lower, concomitant with a greater SR Ca
2+
 pumping rate 70 
(P<0.05) compared to the control condition.  These results demonstrate that increased exposure 71 
to NO2
-
 blunts fatigue development at near-physiological, but not at supra-physiological, PO2 72 
through enhancing SR Ca
2+
 pumping rate in single skeletal muscle fibres.  These findings extend 73 
our understanding of the mechanisms by which increased NO2
-
 exposure can mitigate skeletal 74 









The gaseous signalling molecule, nitric oxide (NO), was first recognized as an endothelium-82 
derived smooth muscle relaxant (Ignarro et al., 1987; Murad et al., 1978).  However, it is now 83 
appreciated that NO can also impact a wide array of physiological processes in skeletal muscle 84 
(Stamler and Meissner, 2001; Suhr et al., 2013).  It is well established that NO can be produced 85 
by the NO synthase (NOS) enzymes, which catalyse the five-electron oxidation of L-arginine to 86 
NO and L-citrulline (Moncada & Higgs, 1991).  More recently, an alternative, O2-independent 87 
pathway for NO generation has been identified in which inorganic nitrate (NO3
-
) can be 88 
sequentially reduced to nitrite (NO2
-
) and then to NO (Clanton, 2019; Lundberg & Weitzberg, 89 
2009, 2010).  Importantly, dietary supplementation with NO3
-
, which increases circulating 90 
plasma [NO2
-
], has been shown to improve skeletal muscle perfusion (Ferguson et al., 2013, 91 
2015), contractile and metabolic efficiency (Bailey et al., 2010; Fulford et al., 2013; Larsen et 92 
al., 2011; Vanhatalo et al., 2011) and contractility (Coggan et al., 2015a; Haider & Folland, 93 
2014; Hernández et al., 2012; Whitfield et al., 2017), and to blunt the development of skeletal 94 
muscle fatigue (Bailey et al., 2009, 2010; Porcelli et al., 2015; Wylie et al., 2013).   95 
 96 
The chemical reduction of NO2
-
 to NO is increased as PO2 (Castello et al., 2006) and pH (Modin 97 
et al., 2001) decline.   There is evidence that dietary NO3
-
 supplementation is more effective at 98 
improving skeletal muscle oxygenation and metabolism and delaying fatigue in hypoxia 99 
compared to normoxia (Kelly et al., 2014; Vanhatalo et al. 2011).  Moreover, NO3
-
 100 
supplementation increases force production (Hernández et al., 2012) and perfusion (Ferguson et 101 
al., 2013) of fast-twitch (type II) skeletal muscle, which exhibits a lower pH (Tanaka et al., 102 
2016) and PO2 (McDonough et al., 2005) during contractions, compared to slow-twitch (type I) 103 
skeletal muscle.  Therefore, the existing evidence suggests that the potential for NO3
-
 104 
supplementation to improve skeletal muscle function may depend on intramuscular pH and PO2. 105 
 106 
Although several studies have reported improved exercise economy and/or performance after 107 
short-term (3-7 days) (e.g., Bailey et al., 2009, 2010; Larsen et al., 2007, 2011; Porcelli et al., 108 
2015; Whitfield et al., 2016) and acute (Wylie et al., 2013) dietary NO3
- 
supplementation, the 109 





supplementation has been reported to improve exercise economy in association with (Larsen et 111 
al., 2011), or independently of (Whitfield et al., 2016), improved efficiency of mitochondrial 112 
oxidative phosphorylation (i.e., a higher P/O ratio).  Alternatively, an attenuated high-energy 113 
phosphate cost of sub-maximal (Bailey et al., 2010) and maximal (Fulford et al., 2013) skeletal 114 
muscle force production has been observed following short-term NO3
- 
supplementation.  It is 115 
well documented that a significant portion of the energy liberated from high-energy phosphate 116 
metabolism is coupled to skeletal muscle Ca
2+
 handling (Barclay, 2015; Walsh et al., 2006).  117 
Accordingly, alterations in skeletal muscle Ca
2+
 handling might play an important role in 118 
improving skeletal muscle function after NO3
-
 ingestion.  In line with this postulate, increased 119 




]c) have been observed in single mouse flexor 120 
digitorum brevis (FDB) myocytes after short-term (i.e., 7 days) in vivo NaNO3 supplementation 121 
(Hernández et al., 2012).  Moreover, NaNO3 supplementation increased tetanic contractile force 122 
(Hernández et al., 2012) and the content of the Ca
2+
 handling proteins, calsequestrin 1 (CASQ1) 123 
and the dihydropyridine receptor (DHPR) in type II extensor digitorum longus muscle, but not in 124 
type I soleus muscle (Hernández et al., 2012; Ivarsson et al., 2017; cf Whitfield et al., 2017).  125 
Acute exposure to NO2
-
 has also been reported to increase [Ca
2+
]c in isolated skeletal muscle 126 
fibres during tetanic contractions (Andrade et al., 1998b).  Therefore, alterations in skeletal 127 
muscle Ca
2+
 handling appears to play an important role in the improvement in skeletal muscle 128 
function after acute and short-term NO3
- 
supplementation.   129 
 130 
Given that skeletal muscle fatigue and perturbations to Ca
2+
 handling appear to develop in 131 
synchrony (Allen et al., 2008; Westerblad & Allen, 1994), improved Ca
2+
 handling after NO3
-
 or 132 
NO2
-
 treatment (Andrade et al., 1998b; Hernández et al., 2012) might be expected to delay 133 
skeletal muscle fatigue.  However, it has yet to be determined whether acutely exposing skeletal 134 
muscle fibres to NO2
-
 can abate fatigue development, and to what extent this might be 135 
attributable to alterations in Ca
2+
 handling, during repeated tetanic contractions.  A limitation of 136 




 administration on skeletal muscle 137 
force production and Ca
2+
 dynamics is the high experimental PO2 (95% O2) of the perfusate 138 
employed in these studies (Andrade et al., 1998b; Hernández et al., 2012).  This is important 139 
because the intracellular PO2 in muscle fibres during intense skeletal muscle contractions is 140 
lowered from ~5% O2 (~30 Torr ) to ~ 0.5% O2 (~2-5 Torr) (Hirai et al. 2018; Richardson et al., 141 
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1995), and there is evidence that the effects of NO on skeletal muscle contractility and [Ca
2+
]c is 142 
influenced by the PO2 (Eu et al., 2003).  Accordingly, further research is required to assess the 143 
effects of NO2
-
 administration on skeletal muscle contractility, fatigue and [Ca
2+
]c at a PO2 that 144 
better reflects that which is manifest in vivo during intense contractions.   145 
 146 
The purpose of the present study was to assess the effects of acute NO2
-
 administration on Ca
2+
 147 
handling, evoked force and fatigue resistance in single intact mouse FDB myocytes at both a 148 
near-physiological PO2 and the more commonly used supra-physiological PO2.  The single muscle 149 
fibre model utilised in the current study also allowed us to isolate the effects of NO2
-
 150 
administration on intramyocyte processes in the absence of altered extramyocyte processes such 151 
as perfusion.   We hypothesized that skeletal muscle Ca
2+
 handling and contractility would be 152 
improved, and fatigue development would be delayed, in FDB fibres after NO2
-
 incubation at a 153 
physiological, but not a supra-physiological, PO2. 154 
 155 





Ethical approval 159 
All procedures were approved by the University of California, San Diego Institutional Animal 160 
Care and Use Committee (UCSD-IACUC). The experiments in the present investigation comply 161 
with The Journal of Physiology policy for animal studies, as described by Drummond (2009). 162 
Adult male mice (12-16 weeks old; C57BL/6J; The Jackson Laboratory, Bar Harbor, ME; a total 163 
of 22 mice were utilized in the present study) were allowed access to water and food ad libitum, 164 
and were euthanized by an intraperitoneal overdose of sodium pentobarbital (sleep-away; 150 165 
mg/kg). Death was confirmed by absence of movement, heartbeat, and response to toe pinching 166 
followed by rapid cervical dislocation to ensure euthanasia. 167 
 168 
Single mouse fibre isolation  169 
After euthanasia, the FDB muscles from both posterior feet were quickly excised and individual, 170 
intact single muscle fibres (total of 28 fibres used in this study) were microdissected from the 171 
whole muscle and transferred to an intact muscle fibre system (model 1500A with force 172 
transducer model 403A, Aurora Scientific Inc., Aurora, ON, Canada), as described previously 173 
(Nogueira et al., 2018). The intact muscle fibre system was placed on the stage of a Nikon 174 
inverted microscope with a 40x long distance Fluor objective. During the experimental 175 
procedures, fibres were superfused with Tyrode’s solution [in mM: 121 NaCl, 5 KCl, 1.8 CaCl2, 176 
0.5 MgCl2, 0.4 NaH2PO4, 24 NaHCO3, 5.5 glucose and 0.1 K2EGTA, constantly bubbled with 177 
5% CO2 (for solution pH 7.4) and either 20% O2 or 2% O2 as described below]. All experimental 178 
procedures were performed at 22ºC. 179 
 180 
Isometric force measurements and experimental protocol 181 
Isolated single mouse fibres were electrically stimulated using a Grass S88X stimulator (Quincy, 182 
MA) and signal was acquired and analysed as described previously (Gandra et al., 2018). Force 183 
development (in mN) was normalized to the cross-sectional area (in mm
2
) determined from the 184 
diameter of the fibre (32.8 ± 1.4 µm diameter; n=22 fibres, mean ± SE). After being mounted 185 
into an experimental chamber, fibres were loaded or injected with the respective fluorescent 186 
probe (BCECF-AM or FURA-2) or not treated with any fluorescent probe (as described above). 187 
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All fibres underwent a 30 min of constant superperfusion with Tyrode´s solution bubbled with 188 
20% O2, 5% CO2 (for extracellular pH 7.4), and N2 balance followed by electrical stimulations to 189 
evoke contractions.  Fibre length was then adjusted to achieve optimal isometric tetanic force at 190 
100 Hz (350 ms trains, 0.5 ms pulses, 8 V; L0). Thereafter, fibres rested for a further 30 min in 191 
constant superperfusion with Tyrode´s solution bubbled with either 20% O2 (for extracellular PO2 192 
of ~156 Torr) or 2% O2 (for extracellular PO2 of 15.6 ± 0.01 Torr, mean ± SE). The chamber was 193 
sealed with a glass cover slip in order to maintain the oxygen tension for the experimental 194 
protocol. Oxygen tension of the solution was measured using a needle-type housing fibre optic 195 
oxygen microsensor (OXYMICRO, World Precision Instruments, Sarasota, FL) immersed in the 196 
experimental chamber solution.  197 
 198 
Initially, all fibres were electrically stimulated at different frequencies of pulse stimulation 199 
(force-frequency curve; FF; 1-150 Hz; 100 s rest between trains, FF#1).  After 5 min of rest, 200 
fibres completed a fatigue-inducing contraction protocol (Fatigue #1) comprising a series of 100 201 
Hz trains with the stimulation frequency increased every 2 min (0.25, 0.3, 0.36, 0.43, 0.52, 0.62, 202 
0.75, 0.9, 1.1 trains/s) until task failure, which was defined as the time required for force to 203 
decrease by 50%. Immediately following task failure (control), the fibre was superperfused with 204 
a 100 µM NaNO2 solution solubilized in Tyrode´s (or modified Tyrode´s when pHi was 205 
measured, see below) and allowed to recover for 60 min. Subsequently, the FF and fatiguing 206 
contraction protocols described above were repeated (FF#2 and Fatigue #2, respectively).  A 207 
schematic of the experimental protocol is presented in Figure 1.  In experiments performed on 208 
fibres microinjected with FURA-2, the chamber was switched to a Tyrode´s solution containing 209 
10 mM caffeine immediately following the last train of the FF curve and fatigue to evoke a 210 
single 120 Hz train and 100 Hz trains, respectively.  The concentration of NaNO2 was chosen 211 
based on the study of Andrade et al., 1998b, who reported alterations in skeletal muscle force 212 




 and pH assessment during contraction  215 
Cytosolic calcium concentration ([Ca
2+
]c) and intracellular pH (pHi) changes were obtained by 216 
fluorescence spectroscopy using a Photon Technology International illumination and detection 217 






]c measurements  220 
Single muscle fibres (n=5) were pressure injected using a micropipette filled with the ratiometric 221 
compound, FURA-2 (Life technologies, Carlsbad, CA, USA; 12 mM, diluted in 150 mM KCl 222 
and 10 mM HEPES pH 7.0), followed by 1 h of rest, and subsequent measurement of [Ca
2+
]c as 223 
described previously (Gandra et al., 2018). Fluorescence excitation ratio (340/380 nm; R) was 224 
converted to [Ca
2+




]c = KD• β•[(R – Rmin)/(Rmax – R)]            Eq.1 227 
  228 
From equation 1, KD is the dissociation constant for Ca
2+
-FURA-2, which was set to 224 nM 229 
(Westerblad & Allen, 1991); β (4.51 ± 0.64; n=5 fibres, mean ± SE) is the fluorescence ratio 230 
between high and no [Ca
2+
]c at 380 nm and was determined for each of the contracting fibres as 231 
described previously (Bakker et al., 1993; Andrade et al., 1998a); Rmin (0.24 ± 0.02; mean ± SE ) 232 
and Rmax (5.03 ± 0.84; mean ± SE) are the fluorescence ratios at no cytosolic Ca
2+
 and high Ca
2+
, 233 
respectively, and were determined using an internal in vivo calibration described by Gandra et al. 234 




]c was calculated by averaging the [Ca
2+
]c signal in the final 100 237 




]c before each 238 
contraction (i.e, basal [Ca
2+
]c) was calculated by averaging the signal in the 100 ms preceding 239 
each stimulation. To determine myofilament Ca
2+
 sensitivity, force development data at each 240 
peak [Ca
2+
]c during the force-frequency (FF) curves were fitted with a sigmoidal equation 241 
(Gandra et al., 2018) described in equation 2: 242 
 243 












)]   Eq.2  244 
  245 
From equation 2, P is the force developed at different [Ca
2+
]c, P0 is the maximal force 246 
development, Pmin is the minimum force developed, Ca
2+
50 is the midpoint of the force-[Ca
2+
]c 247 




To determine whether fatiguing contractions altered myofilament Ca
2+
 sensitivity, force 250 
development data during the fatigue-inducing contraction protocol were plotted at each peak 251 
[Ca
2+
]c and fitted with equation 2 to determine Ca
2+
50 during fatigue. However, the first 40 s of 252 
contractions were not used to determine Ca
2+
50 since they represent the phase 1 of fatigue 253 
(Westerblad & Allen, 1991).       254 
 255 
During the contraction protocols, SR Ca
2+
 pumping was measured using the procedures 256 
described by (Nogueira et al. 2018).  Briefly, a SR Ca
2+
 pumping curve was obtained by plotting 257 




]c/dt) during the elevated long tail of [Ca
2+
]c decay (from 100 258 
ms – 3 s after the stimulation period) versus [Ca
2+








 – L                        Eq.3 261 
  262 







), the power function, and the SR Ca
2+
 leak, respectively. In order to 264 
directly compare SR Ca
2+




) between the control and NaNO2 conditions at 265 
the same time-points of the fatigue protocols (first contraction, 80 s of contractions, and the point 266 
of task failure), the curves were fitted with N and L fixed at 4 and 30, respectively.  These values 267 
were based on mean values of  4.4 ± 0.2 for N and 32 ± 4 and for L obtained in individual 268 
experiments (n=5 fibres, mean ± SE), with a maximum increase in least-square error of 15% 269 
(Nogueira et al., 2018).  270 
 271 
pHi measurements  272 
Single muscle fibres (n=5) were loaded with 2’, 7’-bis-(2-carboxyethyl)-5-(and -6)-273 
carboxyfluorescein (BCECF-AM; Life technologies, Carlsbad, CA, USA; prepared as stock 274 
solution of 10 mM in 100% ethanol and diluted in Tyrode´s to final concentration of 10 µM 275 
BCECF-AM and 0.1% ethanol) for 30 min at room temperature. After the incubation period, 276 
excess BCECF-AM was washed out twice with 10 ml Tyrode´s, followed by a 30 min resting 277 
period with constant superperfusion with Tyrode´s. Intracellular pH (pHi) changes during 278 
contractions were performed as described previously (Nogueira et al., 2013). After completing 279 
the experimental protocol, each fibre loaded with BCECF-AM underwent an in vivo calibration 280 
11 
 
procedure, involving 20 min incubation in two different pH buffered solutions (175 mM KCl, 1.2 281 
mM KH2PO4, 0.5 mM MgCl2, 10 mM HEPES, 10 µM nigericin), previously titrated with KOH 282 
to pH 5.0 and 9.0 as the fluorescence signal was detected. To determine the logarithmic 283 
dissociation constant (pKA), another group of fibres (n=3) were loaded with BCECF-AM, 284 
incubated for 20 min in each of the 12 different pH buffered solutions (ranging from pH 5.0 to 285 
pH 9.0), and the fluorescence signal was detected (Nogueira et al., 2013). To convert the 286 
fluorescence signals to pHi, fluorescence excitation ratio (440/490 nm; F) was then converted to 287 
pHi according to equation 4.  288 
 289 
pHi = pKA– log [(F – Fb)/(Fa – F)] – log (Sb/Sa)            Eq. 4 290 
 291 
From equation 4, pKA was set to 7.14 (7.14 ± 0.03, n=3 fibres; mean ± SE).  Sb and Sa are the 292 
fluorescence signals from 440 nm excitation when BCECF is H
+
-free (reached at pH 9.0) and 293 
H
+
-bound (reached at pH 5.0), respectively.  The fluorescence ratio of Sb/Sa was determined as 294 





-free states, respectively, and were determined as 2.56 ± 0.22 for Fa and 8.63 ± 0.35 for Fb 296 
(total of n=8 fibres; mean ± SE).  297 
 298 
When pHi was measured during the contractile protocols, a modified Tydore´s solution was 299 
applied where 20 mM NaCl was substituted with NaLactate (101 mM NaCl, 5mM KCl, 1.8 mM 300 
CaCl2, 0.5 mM MgCl2, 0.4 mM NaH2PO4, 24 mM NaHCO3, 5.5 mM glucose, 0.1 mM EGTA, 301 
0.2% FBS and 20 mM NaLactate). This solution was applied in order to produce contractile-302 
induced changes in intracellular pH in single mouse fibres (Westerblad & Allen, 1992).  303 
 304 
Statistics 305 
The experimental results are presented as mean ± standard deviation (SD). For comparison 306 
between two groups, paired Student’s t-test were used and effect size was calculated using 307 
Cohen’s d. For multiple comparisons, a one-way ANOVA followed by the Tukey test or a two-308 
way ANOVA followed by Bonferroni test was used, as indicated. All the analyses were 309 
conducted using GraphPad Prism® version 4.00 for Windows (San Diego, California, USA).  310 





Influence of PO2 and NaNO2 administration on single fibre fatigue development  314 
To assess the influence of NaNO2 incubation on fatigue development and the potential PO2-315 
dependence of this effect, single muscle fibres were exposed to either a supra-physiological or a 316 
near-physiological PO2 [i.e., with 20% O2 (~150 Torr) or 2% O2 (~15.6Torr), respectively] in the 317 
absence of any injection or loading with fluorescent probes. At 20% O2, time to task failure 318 
following NaNO2 administration was 34 ± 19% shorter compared to standard Tyrode’s solution 319 
(control: 257 ± 94 vs. NaNO2: 159 ± 46 s; d=1.63, P<0.05, Fig. 2A, n=4 fibres). There were no 320 
differences in initial isometric force between the control and NaNO2 fatigue runs at 20% O2 321 
(control: 413 ± 63 vs. NaNO2: 410 ± 69 kPa; P>0.05). However, when fibres were superfused 322 
with 2% O2, which was the smallest extracellular PO2 that did not lower time to task failure 323 
compared to 20% O2 (data not shown), NaNO2 treatment increased time to task failure by 19 ± 324 
18% (control: 538 ± 286 vs. NaNO2: 607 ± 304 s, d=1.83, P<0.05, Fig. 2B, n=4 fibres). There 325 
was also no difference in initial isometric force between the control and NaNO2 fatigue runs at 326 
2% O2 (control: 495 ± 111 vs. NaNO2: 477 ± 98 kPa; P>0.05). There was no difference in time 327 
to task failure between the two fatigue runs at 2% O2 when NaNO2 was absent prior to and 328 
during the second fatigue-inducing contraction protocols (first fatigue run: 330 ± 131 vs. second 329 
fatigue run: 288 ± 143 s; P>0.05, n=4 fibres).  When single muscle fibres were microinjected 330 
with FURA-2 to measure [Ca
2+
]c responses during and between contractions, NaNO2 treatment at 331 
near-physiological PO2 did not increase time to task failure compared to the control condition 332 
(control: 142 ± 33  vs. NaNO2: 165 ± 73 s, d=0.51, P>0.05, n=5 fibres). However, in fibres 333 
loaded with BCECF and perfused with a modified Tyrode’s solution (i.e., with 20 mM 334 
NaLactate) to measure pHi, time to task failure was increased with NaNO2 administration 335 
(control: 291 ± 52 vs. NaNO2: 379 ± 82 s; 31 ± 18% increase; d=1.62, P<0.05; n=5 fibres).  336 
When the fibres from all experiments at near-physiological PO2 were pooled, time to task failure 337 
was enhanced by 21 ± 22% with NaNO2 treatment compared to preceding control condition 338 
(control: 308 ± 217 vs. NaNO2: 368 ± 242 s; d=1.14, P<0.01, Fig. 2C, n=14 fibres). 339 
 340 
Influence of NaNO2 on force and intracellular Ca
2+
 responses during single non-fatiguing 341 
contractions  342 
13 
 
During the single contraction non-fatiguing FF curves, maximal tetanic force was not different 343 
(P>0.05), but sub-maximal force during 20-50 Hz contractions was lowered in the NaNO2 344 
condition compared to the control condition (P<0.01, n=5 fibres; Fig 3A).  For example, evoked 345 
force at 30 Hz was 42 ± 20% lower in the NaNO2 condition (P<0.01).  Peak [Ca
2+
]c was lowered 346 
in the NaNO2 condition at sub-maximal (e.g., by 21 ± 11% at 30 Hz, P<0.01) and maximal (e.g., 347 
by 22 ± 15% at 150 Hz, P<0.05) force development, as well as during 120 Hz contractions 348 
evoked in the presence of 10 mM caffeine (by 32 ± 21%), compared to the control condition 349 
(P<0.05). In fibres that were superfused with 2% O2 but not treated with NaNO2, maximal and 350 
submaximal forces were not different between the first and the second FF curves (data not 351 
shown, n=4, P>0.05). When isometric force development (shown in Fig 3A) was plotted against 352 
[Ca
2+
]c (shown in Fig. 3B) across the FF curve, there were no differences between the control 353 
and NaNO2 conditions (Fig. 3C). Indeed, the midpoints of the force-[Ca
2+
]c curves were not 354 
different between the control and NaNO2 conditions (e.g., Ca
2+
50 was 474 ± 154 nM vs. 472 ± 355 
122 nM for control and NaNO2, respectively, P>0.05, n=5 fibres).   356 
 357 
Influence of NaNO2 on intracellular Ca
2+
 responses during repeated fatigue-inducing 358 
contractions 359 
There was no difference in peak [Ca
2+
]c achieved during the evoked contractions between the 360 
control and NaNO2 conditions throughout the fatigue-inducing contraction protocols (P>0.05, 361 
Fig. 4A).  However, after 100 s of the fatigue-inducing contraction protocol, basal [Ca
2+
]c 362 
following the evoked contractions was lower in the NaNO2 condition (P<0.05).  Moreover, basal 363 
[Ca
2+
]c at the point of task failure was also lower in the NaNO2 condition (109 ± 20 nM) 364 





50), an index for predict the myofilament Ca
2+
 sensitivity, was 366 
determined during the fatigue-inducing contractions and compared with the data obtained in the 367 
FF curves. While the Ca
2+
50 increased during the fatigue-inducing contraction protocol compared 368 
to the value obtained from the FF curve in the control condition (from 474 ± 154 nM to 601 ± 369 
141 nM, P<0.05), the Ca
2+
50 was not different between the fatigue-inducing contraction protocol 370 
and the FF curve in the NaNO2 condition (from 472 ± 122 nM to 566 ± 95 nM, P>0.05, Fig. 4C). 371 
  372 
Influence of NaNO2 on sarcoplasmic reticulum Ca
2+ 
pumping during fatiguing contractions 373 
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There were no differences between the control and NaNO2 conditions in the plot of [Ca
2+
]c decay 374 
rate for each [Ca
2+
]c following the first contraction of the repeated fatigue-inducing contraction 375 
protocol (Fig. 5A). Similarly, the rate of SR Ca
2+
 pumping following the first contraction was not 376 









conditions (P>0.05, Fig. 4D). During the fatigue-inducing contraction protocol, the rate of SR 378 
Ca
2+




) compared to the first contraction 379 




) compared to both the first 380 
contraction and after 80 s of the fatigue-inducing contraction protocol in the control condition 381 
(P<0.05).  Likewise, the rate of SR Ca
2+
 pumping was progressively slowed from the first 382 









during the fatigue-inducing contraction protocol in the NaNO2 condition (P<0.05). After 80 s of 384 
contractions (Fig. 5B) and at the time of task failure (Fig. 5C), the plots of [Ca
2+
]c decay rate for 385 
each [Ca
2+
]c were left-shifted in the NaNO2 condition compared to the control condition. 386 
Moreover, compared to the control condition, the rate of SR Ca
2+
 pumping was 110 ± 78% 387 
(d=0.63) and 212 ± 105% (d=0.97) higher with NaNO2 treatment after 80 s of contractions (Fig. 388 
5E) and at the time of task failure (Fig. 5F), respectively, during the fatigue-inducing contraction 389 
protocol (P<0.05).  390 
  391 
Intracellular pH changes during fatiguing contractions 392 
Compared to the resting values, pHi at task failure was lower in both the control (Pre: 7.46 ± 0.23 393 
vs. Post: 7.34 ± 0.22) and NaNO2 (Pre: 7.46 ± 0.24 vs. Post: 7.25 ± 0.21) conditions (P<0.0001, 394 
n=5 fibres, Fig. 6).  There were no differences in pHi between the control and NaNO2 conditions 395 
over the first 300 s of the fatigue-inducing contraction protocol (P>0.05).  However, the change 396 
in pHi from the start to the end of the fatigue-inducing contraction protocol was greater in the 397 
NaNO2 condition (-0.20 ± 0.04) compared to the control condition (-0.12 ± 0.05, P<0.05).   398 
 399 





The important original findings from this study were that NaNO2 exposure delayed fatigue 403 
development in single mammalian skeletal muscle fibres at a near-physiological PO2, but 404 
expedited fatigue development at a supra-physiological PO2, during a repeated tetanic contraction 405 
protocol.  Moreover, when single skeletal muscle fibres were incubated with NaLactate to 406 
replicate the contraction-induced decline in pHi that is manifest in vivo, the blunting of fatigue 407 
development with NaNO2 compared to the control condition at a physiological PO2 was greater 408 
than the same comparison without NaLactate coincubation.  The delayed fatigue development 409 
with NaNO2 administration did not impact peak [Ca
2+
]c during the fatiguing contraction protocol 410 
but blunted the progressive decline in SR Ca
2+
 pumping rate and the associated increase in basal 411 
[Ca
2+
]c in the recovery period between contractions.  Incubation with NaNO2 also alleviated the 412 
decline in myofilament Ca
2+
 sensitivity during the fatiguing contraction protocol.  There was no 413 
difference in pHi between the NaNO2 and control conditions over the first 300 s of the fatigue-414 
inducing contraction protocol, but pHi was lower at task failure in the NaNO2 condition 415 
compared to the control condition.  These results suggest that, at a PO2 comparable to that 416 
observed in human skeletal muscle during fatigue-inducing contractions (Richardson et al., 417 
1995), and in the absence of any alterations in perfusion, NO2
-
 treatment can delay the 418 
development of fatigue in single skeletal muscle fibres by improving SR Ca
2+
 pumping, 419 
maintaining Ca
2+
 sensitivity, and permitting the attainment of a lower pHi.  These findings 420 
extend our understanding of the mechanisms by which increased muscle NO2
-
 exposure, as 421 
occurs following dietary NO3
-
 supplementation (Gillard et al., 2018; Wylie et al., in press), can 422 
blunt skeletal muscle fatigue and suggest that the potential for NO2
-
 administration to attenuate 423 
fatigue development is PO2- and pH-dependent. 424 
 425 
Influence of NaNO2 administration on time to task failure at a near-physiological PO2 426 
Incubation with NaNO2 at a near-physiological PO2 increased time to task failure by 19% 427 
compared to the control condition with no fluorophore loading.  Although NaNO2 administration 428 
at a near-physiological PO2 did not increase time to task failure in fibres microinjected with 429 
FURA-2 to assess [Ca
2+
]c dynamics, when these data were combined with data from fibres with 430 
no fluorophore loading, time to task failure was extended by 15%.  The greatest increase (31% 431 
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compared to the respective control condition) in time to task failure with NaNO2 incubation in 432 
the current study was observed when skeletal muscle fibres were co-incubated with a near-433 
physiological PO2 and NaLactate to facilitate a decline in pHi (Westerblad & Allen, 1992) and 434 
thus better reflect the pHi dynamics in human skeletal muscle in vivo (Vanhatalo et al., 2011).  435 
The mean improvement in time to task failure with NaNO2 incubation compared to the respective 436 
control conditions in the experiments completed with (FURA-2 and BCECF-AM) and without 437 
fluorophores was 21% at a near-physiological PO2 in the current study. 438 
 439 
It has been reported that intracellular PO2 in both rodent and human skeletal muscle fibres drops 440 
from ~30 Torr at rest to ~3-4 Torr during intense exercise (Hirai et al., 2018; Richardson et al., 441 
1995).  The extracellular PO2 was set at ~15 Torr (2% O2) in the current study as preliminary 442 
experiments revealed this to be the smallest extracellular PO2 that did not lower time to fatigue in 443 
single skeletal muscle fibres compared to experiments conducted at 20% O2, which suggest that 444 
at 15 Torr fibres were not under hypoxic conditions during contractions. Furthermore, the 445 
extracellular PO2 used in the present work closely reflects the PO2 in the interstitial space between 446 
the capillaries and muscle fibres (Hirai et al., 2018), and was intended to replicate the 447 
intracellular PO2 during contractions in humans in vivo (Richardson et al., 1995). Although the 448 
control fatigue-inducing protocol always preceded the NaNO2 fatigue-inducing protocol, there 449 
was no difference in evoked isometric force in the first tetanic contraction of the control and 450 
NaNO2 fatigue-inducing protocols, and there was no difference in time to task failure between 451 
two fatigue-inducing protocols at 2% O2 without NaNO2 administration.  Therefore, our results 452 
suggest that, at a near physiological PO2, the blunted rate of fatigue development in the second 453 
fatigue-inducing protocol completed with NaNO2 administration was not confounded by 454 
differences in initial force production or fatigue development between the first and second 455 
fatigue-inducing contraction protocols.  456 
 457 
Influence of NaNO2 administration on time to fatigue at a supra-physiological PO2 458 
In contrast to the delayed rate of fatigue development with NaNO2 administration at a near 459 
physiological PO2, fatigue development was expedited when NaNO2 was administered at a supra-460 
physiological PO2 of 20% O2 (~150 Torr) in the present study.  It has been reported that 461 
sarcomere shortening and [Ca
2+
]c are greater in collagenase-digested single FDB muscle fibres 462 
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excised from wild-type mice and stimulated by single twitches at 1% O2 compared to 20% O2, 463 
and that these effects are abolished in fibres excised from nNOS knock-out mice (Eu et al., 464 
2003).  These findings suggest that, at least in the unfatigued state, SR Ca
2+
 handling and skeletal 465 
muscle contractility are improved by NO production at a physiological PO2 compared to a supra-466 
physiological PO2. It has been suggested that the one-electron reduction of NO2
-
 to NO is 467 
inversely related to PO2 and that the oxidation of NO2
-
 and NO to NO3
-
 is increased at a higher 468 
PO2 (Lundberg & Weitzberg, 2009, 2010).  The greater production of superoxide in hyperoxia 469 
(Clanton, 2007) will also act to scavenge NO generated from NO2
-
 reduction (Sjöberg & Singer, 470 
2013) leading to the formation of the potent oxidising agent, peroxynitrite (Radi, 2013).  This 471 
potential for increased peroxynitrite synthesis with NO2
-
 administration at a supra-physiological 472 
PO2 might have contributed to the earlier attainment of task failure compared to the control 473 
condition (Dutka et al., 2012; Supinski et al., 1999).  There is also evidence that hydrogen 474 





through the enzyme, catalase (Heppel & Porterfield, 1949).  Therefore, the PO2-dependent effects 476 
of NO2
-
 on fatigue development might be linked to the proportion of NO2
-
 that is reduced to NO 477 
and its interaction with reactive oxygen species.  Collectively, our results suggest that the effect 478 
of NaNO2 administration on fatigue development in single skeletal muscle fibres is PO2- and pH-479 
dependent with the greatest positive effect manifest when PO2 and pHi dynamics most closely 480 
resemble those that are exhibited in human skeletal muscle in vivo.   481 
 482 
Influence of NaNO2 administration on skeletal muscle Ca
2+
 handling  483 
In addition to measuring fatigue development, [Ca
2+
]c transients were assessed during a series of 484 
single non-fatiguing contractions and during subsequent repeated fatigue-inducing tetanic 485 
contractions at a near physiological PO2 in the absence and presence of NaNO2.  There were no 486 
differences in isometric force during a series of single contractions evoked prior to and 60 min 487 
following the completion of a repeated contraction fatigue-inducing protocol suggesting that 60 488 
min of recovery was sufficient to restore isometric force to baseline.  Accordingly, any effect of 489 
NO2
-
 on contractility during the second series of single non-fatiguing contractions would not be 490 
expected to be confounded by the preceding fatigue-inducing contraction protocol.  During the 491 
series of single non-fatiguing contractions completed 60 min after the end of the first bout of 492 
fatiguing contractions and with NaNO2
-
 incubation, isometric force during single submaximal 493 
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(20-50 Hz) contractions was depressed compared to the initial control condition, but not at near-494 
maximal or maximal (>50 Hz) contractions.  [Ca
2+
]c was lower with NO2
-
 treatment during 495 
single 30-150 Hz contractions and during a single 120 Hz contraction in the presence of 10 mM 496 
caffeine to evoke maximum SR Ca
2+
 release, but due to the sigmoidal nature of the force-Ca
2+
 497 
relationship, the decreased in peak [Ca
2+
]c at high pulse-frequencies with NaNO2 did not alter the 498 
maximum force developed.  Therefore, the suppression of isometric force development during 499 
sub-maximal contractions with NO2
-
 exposure was a function of lower SR Ca
2+
 release with no 500 
change in Ca
2+
 sensitivity.   In contrast, and despite administering the same NO2
-
 dose as the 501 
current study, [Ca
2+
]c was increased, and isometric force was attenuated in single mouse skeletal 502 
muscle fibres with NO2
-
 treatment at 95% O2 in a previous study by Andrade et al. (1998b).  503 
Since this reduction in myofibrillar Ca
2+
 sensitivity with NO2
-
 treatment was also observed 504 
following the administration of different NO donors (Andrade et al., 1998b), these findings 505 
suggest that the effects of NO2
-
 on SR Ca
2+
 handling are NO-mediated or that NO2
-
 and NO 506 
impact SR Ca
2+





 handling and isometric force in the current study and the study by Andrade et al. 508 
(1998b) is likely a function of the inter-study difference in the experimental PO2 (Eu et al., 2003) 509 
and its influence on the crosstalk between redox and nitroso signalling (Spencer & Posterino, 510 
2009).  While it is unclear why NO2
-
 administration suppressed isometric force production and 511 
peak [Ca
2+
]c during 20-50 Hz submaximal contractions, and did not change isometric force 512 
production during maximal/near-maximal contractions at 100 Hz, these observations are in line 513 
with previous findings that NO donors are more likely to impair force production during unfused 514 
tetanus compared to fused tetanus (Maréchal and Gailly, 1999; Murrant et al., 1997).    515 
 516 
During the fatigue-inducing repeated tetanic contraction protocol, peak [Ca
2+
]c during 517 
contractions declined, basal [Ca
2+
]c following contractions increased and myofibrillar Ca
2+
 518 
sensitivity was lowered as the fatigue protocol progressed.  These perturbations to SR Ca
2+
 519 
handling are consistent with previous reports and are important contributors to the development 520 
of skeletal muscle fatigue (Allen et al., 2008; Westerblad & Allen, 1994).  There was no 521 
difference in peak [Ca
2+
]c during contractions between the NaNO2 and control conditions 522 
throughout the fatigue run.  However, after 80 s of the fatigue run, the slowing in SR Ca
2+
 523 
pumping and the resultant increase in basal [Ca
2+





 treatment.  Therefore, the blunted fatigue development in the NO2
-
 trial compared to the 525 
control trial appears to be linked to a better maintenance of SR Ca
2+
 pumping.  The pumping of 526 
Ca
2+
 by the SR is an active process that is coupled to the function (Ca
2+
 affinity and the coupling 527 
between ATP hydrolysis and Ca
2+
 transport) of the SR Ca
2+
-ATPase (SERCA).  SERCA 528 
function is regulated by the phosphorylation status of two proteins with similar structures, 529 
phospholamban, which is mostly expressed in cardiac myocytes and in slow-twitch muscle 530 
fibres, and sarcolipin, which is mostly expressed in skeletal muscle fibres (Pant et al., 2016).  531 
Specifically, phosphorylated phospholamban and sarcolipin can improve SERCA function, 532 
whereas dephosphorylated phospholamban and sarcolipin can compromise SERCA function 533 
(Tupling, 2009).  It has been reported that NO2
-
 administration can increase the amount of 534 
phosphorylated phospholamban in striated muscle through nitrite reductase dependent NO 535 
production (Huang et al., 2013). Therefore, it is possible phosphorylation of phospholamban 536 
and/or sarcolipin might have contributed to the improved maintenance of SR Ca
2+
 pumping 537 
during the fatigue-inducing contraction protocol completed with NaNO2 treatment at a low PO2 538 
compared to the control trial in the current study.  Moreover, since the rate of SR Ca
2+
 pumping 539 
is inversely related to basal [Ca
2+
]c accumulation during repetitive contractions (Nogueira et al., 540 
2013, 2018), the lower basal [Ca
2+
]c accumulation during the fatigue-inducing contraction 541 
protocol would also likely have contributed to the better maintenance of SR Ca
2+
 pumping 542 
during the NO2
-
 trial.  Lowering the energy cost of actomyosin ATPase, through inhibiting cross-543 
bridge cycling, has also been reported to abate the progressive slowing in SR Ca
2+
 pumping rate 544 
during fatiguing contractions (Nogueira et al., 2013).  It has been reported that increasing NO2
-
 545 
via short-term dietary NO3
-
 supplementation can lower the high-energy phosphate cost of sub-546 
maximal (Bailey et al., 2010) and maximal (Fulford et al., 2013) skeletal muscle force 547 
production, which is compatible with findings from single intact skeletal muscle fibres that the 548 
energy cost of skeletal muscle contraction impacts SR Ca
2+
 pumping rate during fatiguing 549 
contractions (Nogueira et al., 2013).   550 
 551 
Compared to the single non-fatiguing contractions completed during the construction of the 552 
force-frequency curve, myofilament Ca
2+
 sensitivity declined across the fatigue-inducing 553 
contraction protocol in the control trial, but not the NaNO2 trial.  Therefore, improved 554 
preservation of myofilament Ca
2+
 sensitivity might have contributed to the slower rate of fatigue 555 
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development in the NaNO2 trial.  It has been reported that treatment with NO donors can S-556 
nitrosylate cysteine residues in the myosin heavy chain leading to slowed cross-bridge cycling 557 
(Nogueira et al., 2009), but increased force per power stroke (Evangelista et al., 2010).  Since 558 
NO2
-
 administration has also been reported to promote S-nitrosylation in striated muscle (Kovács 559 
et al., 2015), the improved maintenance of Ca
2+
 sensitivity with NaNO2 administration in the 560 
current study might therefore be a function of direct NO2
-
 action on the myofilaments.  561 
Alternatively, NO2
-
 administration might have improved myofilament Ca
2+
 sensitivity indirectly 562 
through attenuating ROS production (Yang et al., 2015), or thwarting ROS-mediated oxidation 563 
of the myofilaments (Moonpanar & Allen, 2006). 564 
 565 
Influence of NaNO2 administration on skeletal muscle pH 566 
Since a decline in muscle pH has been reported to compromise myofilament Ca
2+
 sensitivity 567 
(Fabiato & Fabiato, 1978) and SERCA function (Wolosker et al., 1997), and since NO has been 568 
reported to inhibit glycolysis via S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase 569 
(Mohr et al., 1996), pHi was assessed to provide insight into the potential mechanisms for 570 
improved Ca
2+
 handling in the NaNO2 trial.  Since pHi was not different between the NaNO2 and 571 
control trials over the first 300 s of the fatigue run, the results presented in this study suggest that 572 
the improved maintenance of myofilament Ca
2+
 sensitivity and SR Ca
2+
 pumping rate in the 573 
NaNO2 trial extended time to task failure and permitted the attainment of a lower pHi at task 574 
failure compared to the control condition.   575 
 576 
Limitations and areas for further research 577 
We combined the time to task failure data from FURA-2 injected fibres and non-injected fibres 578 
as time to task failure was not significantly different with NaNO2 compared to the control 579 
condition in FURA-2 microinjected fibres.  Therefore, it should be acknowledged that the 580 
experiments in FURA-2 injected fibres to assess the effects of NaNO2 administration on Ca
2+ 
581 
handling and fatigue at a near-physiological PO2 in the current study were underpowered.  When 582 
the data from FURA-2 injected fibres and non-injected fibres were combined, time to task failure 583 
was significantly extended in the NaNO2 condition, consistent with the experiments where 584 
NaNO2 was co-incubated with NaLactate to facilitate a decline in pHi.  Therefore, this approach 585 
does not undermine the conclusion that acute NaNO2 administration can delay fatigue 586 
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development at a near-physiological PO2 and we have based our conclusions on the effect of 587 





]c and force during 20-50 Hz isometric contractions in the current study, 589 
but elevating plasma [NO2
-
] via chronic NO3
-
 supplementation increased these variables in the 590 
same experimental model (Hernández et al., 2012), we cannot exclude the possibility that 591 
skeletal muscle contractility, fatigue, and Ca
2+
 handling might be enhanced to a greater extent 592 
after chronic NO3
-
 supplementation.  It should be noted that since mammalian plasma nitrite is 593 
significantly lower (i.e., at high nanomolar range) after NO3
-
 ingestion (e.g., Wylie et al., 2013) 594 
compared to the 100 µM NaNO2
-
 that was used to perfuse the skeletal muscle fibres in the 595 
present investigation, the dose of  NO2
-
 administered in the current study was supraphysiological.  596 
Furthermore, since human skeletal muscles do not manifest the same changes in Ca
2+
-handling 597 
proteins following a 7-day NO3
-
 supplementation (Whitfield et al., 2017) previously detected in 598 
rodent skeletal muscle (Hernández et al., 2012), the extent to which our findings translate to 599 
humans is unclear and in need of further research.   600 
 601 
While fatigue development was attenuated concomitant with improved Ca
2+
 handling following 602 
NaNO2 administration at a physiological PO2, Ca
2+
 handling was not assessed during the 603 
supraphysiological PO2 experiments in the current study.  Therefore, the mechanisms for the 604 
more rapid fatigue development with NaNO2 administration at a supraphysiological PO2 remains 605 
to be determined.  Moreover, although the contraction-induced pHi changes observed in the 606 
present study were qualitatively similar to the contraction-induced pHi changes in human skeletal 607 
muscle in vivo, it should be acknowledged that the solution that all fibres were superfused with 608 
was bubbled with 5% CO2 for an extracellular final pH ~7.4.  Therefore, pHi was higher in the 609 
present study compared to human skeletal muscle completing fatiguing contractions in vivo.  It is 610 
also acknowledged that a limitation of our study is the lack of measurement of NO/ROS markers.  611 
Since the NO fluorescent probes, DAF-FM and DAF-2, do not detect NO at low oxygen tensions 612 
(Namin et al, 2013), these probes could not be employed to assess myofiber NO production from 613 
NO2
-
 reduction in our study.  Further research is required to assess the effects of increased 614 
skeletal muscle NO2
-
 exposure on NO and ROS signalling in skeletal muscle.    615 
 616 
Translational Perspective  617 
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Over the past decade there has been significant interest in supplementing the diet with NO3
-
 to 618 
enhance exercise economy and performance (Jones, 2014), but the underpinning mechanisms for 619 
these effects were unclear.  The present study indicates that NaNO2 administration can delay 620 
fatigue development, improve the maintenance of myofilament Ca
2+
 sensitivity and attenuate the 621 
fatigue-induced slowing in SR Ca
2+
 reuptake during repeated tetanic contractions in ex vivo 622 
skeletal muscle fibres at a near-physiological PO2 of 2% O2.  These findings using a single 623 
skeletal muscle fibre model also demonstrate that increased NO2
-
 exposure can blunt skeletal 624 
muscle fatigue development independent of any alterations in skeletal muscle perfusion by 625 
improving skeletal muscle Ca
2+
 handling.  Therefore, our findings offer novel insights into some 626 
of the mechanisms that might underpin the ergogenic effects of increased skeletal muscle NO2
-
 627 
exposure, which might have implications for improving understanding of how dietary NO3
-
 628 
supplementation is ergogenic in humans during high-intensity endurance exercise.   629 
 630 
In addition to evoking positive effects in skeletal muscle, NO3
-
 supplementation or 631 
administration of NO donors can improve Ca
2+
 handling and contractile function in 632 
cardiomyocytes (Pironti et al., 2016; Tocchetti et al., 2007).  There is also evidence to suggest 633 
that NO3
-
 supplementation can improve skeletal muscle (Coggan et al., 2015b) and cardiac 634 
(Zamani et al., 2015) function, and exercise capacity (Coggan et al., 2018; Zamani et al., 2015) 635 
in heart failure patients.  Therefore, increased NO2
-
 exposure following NO3
-
 supplementation 636 
might have important therapeutic application in patients with diseases of the cardiovascular 637 
system.    638 
 639 
In conclusion, acute treatment with NaNO2 delayed time to task failure in intact skeletal muscle 640 
fibres at a physiological PO2 during a repeated tetanic isometric contraction protocol.  The 641 
greatest attenuation of fatigue development was observed when NaLactate was co-administered 642 
with NaNO2 at 2% O2 to elicit similar pHi response dynamics to those manifest in vivo.  643 
Conversely, task failure was attained earlier following NaNO2 administration when assessed at a 644 
supra-physiological PO2 equivalent to 20% O2.  The delay in fatigue development following 645 
NaNO2 administration at 2% O2 was accompanied by improved maintenance of myofilament 646 
Ca
2+
 sensitivity, increased SR Ca
2+
 pumping and a lower basal [Ca
2+
]c in the recovery period 647 
between contractions, and a greater decline of pHi.  Therefore, NaNO2 administration can delay 648 
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fatigue development in intact, ex vivo skeletal muscle fibres at a near-physiological PO2, with this 649 
effect linked to improved myocyte Ca
2+
 handling.  These results provide new insight into the 650 
mechanisms by which increased NO2
-
 exposure can mitigate skeletal muscle fatigue 651 
development and the ergogenic potential of dietary NO3
-
 ingestion. 652 
    653 
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FIGURE LEGENDS 931 
 932 
Figure 1. Schematic of the experimental protocol. 933 
 934 
Figure 2. Effect of sodium nitrite (NaNO2) incubation on fatigue development at supra-935 
physiological (20% O2, ~156 Torr; Panel A) and near-physiological oxygen tensions (2% 936 
O2, ~15 Torr; Panels B and C) in single skeletal muscle fibres. Panel A illustrates time to task 937 
failure during repeated tetanic contractions performed in fibres not loaded with fluorescent 938 
probes at a supra-physiological PO2 in the absence (fatigue #1; control) or presence of 100 µM 939 
NaNO2 (fatigue #2; n= 4 fibres). Panel B illustrates time to task failure in fibres not loaded with 940 
fluorescent probes performed at near-physiological PO2 in the absence and presence of 100 µM 941 
NaNO2 (n= 4 fibres). Panel C illustrates time to task failure in all fibres from this study (not 942 
loaded and loaded with fluorescent probes) that were performed at near-physiological PO2 in the 943 
absence (fatigue #1; control) or presence of 100 µM NaNO2 (fatigue #2; n= 14 fibres).  The bars 944 
represent group mean data with the lines representing responses in individual muscle fibres.  945 
Data are presented as mean ± SD.  *P<0.05 vs. fatigue #1. 946 
 947 
Figure 3. Sodium nitrite (NaNO2) incubation at a near-physiological oxygen tension (2% 948 
O2, ~15 Torr) does not alter myofibrillar calcium (Ca
2+
) sensitivity during single evoked 949 
non-fatiguing contractions. Panel A illustrates isometric force development in single skeletal 950 
muscle fibres evoked by different frequencies of pulse stimulation before fatigue #1 (FF#1) and 951 





]c) at rest, contractions at different pulse-953 
frequencies, and at 120 Hz stimulation in the presence of 10 mM caffeine. Panel C plots force 954 
development against [Ca
2+
]c at each pulse-frequency. *P<0.05 vs. Control.  Data (n=5 fibres) are 955 
presented as mean ± SD.  956 
 957 
Figure 4. Isometric force development and intracellular cytosolic calcium concentration 958 
([Ca
2+
]c) responses during a repeated fatigue-inducing contraction protocol competed in 959 
the absence and presence of sodium nitrite (NaNO2) at a near-physiological oxygen tension 960 
(2% O2, ~15 Torr). Panel A illustrates the peak [Ca
2+
]c responses up to the time of task failure.  961 
32 
 
Panel B illustrates basal [Ca
2+
]c data, obtained from the 100 ms period before each contraction, 962 
up to the time of task failure (*P<0.05 vs. Control).  Note the blunted increase in basal [Ca
2+
]c in 963 
the NaNO2 condition. Panel C illustrates the change () in basal [Ca
2+
]c from rest to task failure.  964 
The Ca
2+
50 before and during fatiguing contractions are illustrated in Panel D with group mean 965 
responses as bars and individual responses as lines (*P<0.05 vs. FF#1). Data (n=5 fibres) are 966 
presented as mean ± SD.  967 
 968 
Figure 5. Analysis of sarcoplasmic reticulum calcium (Ca
2+
) pumping at different time-969 
points during the fatigue-inducing contraction protocols run in the absence and presence of 970 





]c) dependence of the rate of [Ca
2+
]c decay (-972 
d[Ca
2+
]c/dt) during the “tail” of [Ca
2+
]c decay is illustrated after the first contraction (Panel A), 973 
after 80 s of contractions (Panel B) and the contraction at the time of task failure  (Panel C).  974 
Note the left shifting of the NaNO2 curve compared to the control curve after 80 s of contractions 975 
and at the time of task failure, but not after the first contraction.  The changes in SR Ca
2+
 976 
pumping rate at these time-points are presented in Panels D (first contraction), E (after 80 s of 977 
contractions), and F (time of task failure). *P<0.05 vs. control. Data (n=5 fibres) are presented as 978 
mean ± SD. 979 
 980 
Figure 6. Intracellular pH (pHi) responses during the fatigue-inducing contraction 981 
protocols run in the absence and presence of sodium nitrite (NaNO2) at a near-982 
physiological oxygen tension (2% O2, ~15 Torr). pHi changes during the repeated fatiguing 983 
contractions. *P<0.05 vs. control. 
†
P<0.05 vs initial contraction. Data (n=5 fibres) are presented 984 
as mean ± SD. 985 






